$15 Million Bet On This Healthcare Stock? 3 Stocks Insiders Are Buying
Although US stocks closed slightly lower on Monday, there were a few notable insider trades.
Clarus Shares Gain Post Q2 Results
Clarus Corp (NASDAQ:CLAR) reported second-quarter FY22 sales growth of 57% year-on-year to $114.93 million, beating the consensus of $110.16 million. Domestic…
‘I’m Going To Have To Say Avoid It’: Jim Cramer Urges Waiting Before Buying This Tech Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Charles River Laboratories International Inc (NYSE: CRL).
CARIAD SE Selected Innoviz as Direct LiDAR Supplier for the Segment of Automated Vehicles Within the Volkswagen Brands
Innoviz Technologies Ltd. (NASDAQ: INVZ) (the "Company" or "Innoviz") announced today that its recent design win is with CARIAD
The GEO Group Q2 AFFO $0.69 Up From $0.58 YoY, Sales $588.20M Beat $561.50M Estimate
The GEO Group (NYSE: GEO) reported quarterly earnings of $0.69 per share. This is a 18.97 percent increase over earnings of $0.58 per share from the same period last year.
Caris Life Sciences and Xencor Entered Target Discovery Collaboration and License Agreement for Novel XmAb Bispecific Antibodies; Caris to Receive Upfront Payment and Be Eligible to Receive Up to ~$120M in License Fees, Discovery, Development, Regulato…
Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize health care, and Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and
Pearson, Nikola And Some Other Big Gainers From Monday
U.S. stocks closed slightly lower on Monday, with the Nasdaq Composite dropping around 02%. Here is the list of some big stocks moving higher in the previous session.
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
Gainers
Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
Recap Of Monday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application…
Aerie Shares Gain Following Patient Dosing In Late-Stage Dry Eye Disease Study
Aerie Pharmaceuticals (NASDAQ: AERI) has initiated patient dosing in the Phase 3 registrational COMET-3 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED).